How many drugs treat Malignant neoplasm of brain?

Drug Landscape tracks 2 marketed treatments for Malignant neoplasm of brain (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/malignant-neoplasm-of-brain.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Malignant neoplasm of brain — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Malignant neoplasm of brain (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Malignant neoplasm of brain, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Gliadel	CARMUSTINE	Avet Lifesciences	Alkylating Drug	Glutathione reductase, mitochondrial		1977-01-01
Carmustin	Carmustin	University Hospital Freiburg		Glutathione reductase, mitochondrial

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Avet Lifesciences · 1 drug in Malignant neoplasm of brain
University Hospital Freiburg · 1 drug in Malignant neoplasm of brain

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Malignant neoplasm of brain:

Cite this brief

Drug Landscape (2026). Malignant neoplasm of brain — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/malignant-neoplasm-of-brain. Accessed 2026-06-10.

Malignant neoplasm of brain full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing